Literature DB >> 9152810

Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes.

S Okisaka1, A Murakami, A Mizukawa, J Ito.   

Abstract

Hematoxylin-eosin staining, the TUNEL method for in situ detection of the intranuclear DNA fragmentation, which indicates apoptosis, and electron microscopy were used to study the morphologic changes in specimens from the eyes of 8 patients with secondary glaucoma and 2 normal control eyes to evaluate our hypothesis that apoptosis causes a decrease in retinal ganglion cells in human glaucomatous eyes. The TUNEL method permits identification of intranuclear DNA fragmentation. Apoptosis was found in the ganglion cells of 2 glaucomatous eyes with recent sight loss, and in the ganglion cells of a control eye from a 95-year-old subject, taken at autopsy. Results of our study indicate that a decrease in retinal ganglion cells in glaucomatous eyes is caused by apoptosis. In addition, apoptosis resulting from aging must be considered in order to understand the reduction of retinal ganglion cells in the glaucomatous eyes of elderly patients.

Entities:  

Mesh:

Year:  1997        PMID: 9152810     DOI: 10.1016/s0021-5155(97)00013-0

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  21 in total

Review 1.  Ganglion cell death in glaucoma: what do we really know?

Authors:  N N Osborne; J P Wood; G Chidlow; J H Bae; J Melena; M S Nash
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

2.  Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells.

Authors:  Shuo Yin; Zhong-Feng Wang; Jun-Guo Duan; Lu Ji; Xue-Jing Lu
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

Review 3.  Mechanosensitivity and the eye: cells coping with the pressure.

Authors:  J C H Tan; F B Kalapesi; M T Coroneo
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Imaging apoptosis in the eye.

Authors:  M F Cordeiro; C Migdal; P Bloom; F W Fitzke; S E Moss
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

5.  In Vivo Evaluation of White Matter Integrity and Anterograde Transport in Visual System After Excitotoxic Retinal Injury With Multimodal MRI and OCT.

Authors:  Leon C Ho; Bo Wang; Ian P Conner; Yolandi van der Merwe; Richard A Bilonick; Seong-Gi Kim; Ed X Wu; Ian A Sigal; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

Review 6.  Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.

Authors:  Douglas R Rice; Kasey J Clear; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2016-07-07       Impact factor: 6.222

7.  Death and neuroprotection of retinal ganglion cells after different types of injury.

Authors:  M Vidal-Sanz; M Lafuente; P Sobrado-Calvo; I Selles-Navarro; E Rodriguez; S Mayor-Torroglosa; M P Villegas-Perez
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

8.  Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model.

Authors:  Joseph Caprioli; Yoko Ishii; Jacky M K Kwong
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.

Authors:  Giselle Foureaux; José C Nogueira; Bárbara S Nogueira; Gustavo O Fulgêncio; Gustavo B Menezes; Simone O A Fernandes; Valbert N Cardoso; Renata S Fernandes; Gabriel P Oliveira; Juçara R Franca; André A G Faraco; Mohan K Raizada; Anderson J Ferreira
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-21       Impact factor: 4.799

10.  Bis(zinc-dipicolylamine), Zn-DPA, a new marker for apoptosis.

Authors:  Jacky M K Kwong; Celia Hoang; Reshil T Dukes; Richard W Yee; Brian D Gray; Koon Y Pak; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.